Simon C. Lowry

CIK: 0002044279

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EBS

Emergent BioSolutions Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

EBS
Emergent BioSolutions Inc.
Apr 29, 2026
Award(A)
Direct
100.1K shares-
EBS
Emergent BioSolutions Inc.
Mar 5, 2026
Tax Payment(F)
Direct
10.6K shares at avg. $8.44$90K
EBS
Emergent BioSolutions Inc.
Mar 3, 2026
Award(A)
Employee Stock Option (Right to buy)
Direct
44.8K shares-
EBS
Emergent BioSolutions Inc.
Dec 14, 2025
Tax Payment(F)
Direct
3.5K shares at avg. $11.41$40K
EBS
Emergent BioSolutions Inc.
Mar 6, 2025
Award(A)
Direct
62.5K shares-
EBS
Emergent BioSolutions Inc.
Dec 15, 2024
Award(A)
Direct
29.5K shares-

		Type	Shares	Price		Ownership
Apr 29, 2026	EBS Emergent BioSolutions Inc.	Award(A)	100,111	-	$0	Direct
Mar 5, 2026	EBS Emergent BioSolutions Inc.	Tax Payment(F)	10,636	$8.44	$89,768	Direct
Mar 3, 2026	EBS Emergent BioSolutions Inc.	Award(A) Employee Stock Option (Right to buy)	44,834	-	-	Direct
Dec 14, 2025	EBS Emergent BioSolutions Inc.	Tax Payment(F)	3,543	$11.41	$40,426	Direct
Mar 6, 2025	EBS Emergent BioSolutions Inc.	Award(A)	62,500	-	-	Direct
Dec 15, 2024	EBS Emergent BioSolutions Inc.	Award(A)	29,482	-	$0	Direct

1-6 of 6 transactions

About Lowry Simon C

Lowry Simon C (SEC CIK 0002044279) files insider reports with the SEC as SVP, R&D, CMO of Emergent BioSolutions Inc. (EBS).

Signal8 holds 6 ownership filings by Lowry Simon C (1 Form 3, 5 Form 4), filed between Nov 21, 2024 and May 1, 2026. Those filings report 6 transactions, from Dec 15, 2024 to Apr 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lowry Simon C's filings is in GAITHERSBURG, MD.

Recent filings by Lowry Simon C

Apr 29, 2026: Grant or award of EBS shares (Form 4, code A).
Mar 5, 2026: Tax withholding of EBS shares (Form 4, code F).
Mar 3, 2026: Grant or award of EBS derivative securities (Form 4, code A).
Dec 14, 2025: Tax withholding of EBS shares (Form 4, code F).
Mar 6, 2025: Grant or award of EBS shares (Form 4, code A).

Other insiders filing for Emergent BioSolutions Inc. (EBS)

DeGolyer Donald W, Director
Williams Paul Anthony, SVP, Products Business
Duatschek Stephanie, EVP, CGO
LINDAHL RICHARD S, EVP, Chief Financial Officer
Glessner Coleen, EVP, Quality & Ethics, and CPL
Hartzel William, SVP, Bioservices

How to read Form 4 transaction codes